varenicline has been researched along with Weight Loss in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ermiş, N; Karatas, M; Kayhan-Tetik, B; Parlakpinar, H; Polat, A; Sagır, M; Selçuk, EB; Sungu, M; Taslıdere, E; Vardı, N; Yalçınsoy, M | 1 |
| Heggen, E; Svendsen, M; Tonstad, S | 1 |
| Cocores, JA; Gold, MS | 1 |
1 trial(s) available for varenicline and Weight Loss
| Article | Year |
|---|---|
Smoking cessation improves cardiometabolic risk in overweight and obese subjects treated with varenicline and dietary counseling.
Topics: Adult; Biomarkers; Blood Pressure; Counseling; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Nicotinic Agonists; Norway; Obesity; Prevalence; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Treatment Outcome; Triglycerides; Varenicline; Weight Loss | 2017 |
2 other study(ies) available for varenicline and Weight Loss
| Article | Year |
|---|---|
Evaluation of the cardiovascular effects of varenicline in rats.
Topics: Animals; Antioxidants; Aorta; Apoptosis; Blood Pressure; Cardiovascular Diseases; Cardiovascular System; Caspase 9; Heart; Heart Rate; Lipid Peroxidation; Myocardium; Nicotinic Agonists; Oxidative Stress; Rats, Wistar; Risk Assessment; Time Factors; Tobacco Use Cessation Devices; Varenicline; Weight Loss | 2015 |
Varenicline, appetite, and weight reduction.
Topics: Aged; Alcoholism; Benzazepines; Female; Humans; Psychiatric Status Rating Scales; Quinoxalines; Smoking Cessation; Varenicline; Weight Loss | 2008 |